Increasing trends of pharmaceutical payments to breast cancer specialists in Japan: A retrospective study from 2016 to 2019

The introduction of new drugs often leads to aggressive promotion and potential financial conflicts of interest, which may bias treatment decisions and potentially harm patients. The breast cancer therapeutics market is rapidly evolving globally, and Japan is no exception. This study aimed to analyz...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	PloS one 2024-09, Vol.19 (9), p.e0310880
Hauptverfasser:	Kaneda, Yudai, Yamashita, Erika, Saito, Hiroaki, Gonda, Kenji, Wada, Masahiro, Tanimoto, Tetsuya, Ozaki, Akihiko
Format:	Artikel
Sprache:	eng
Schlagworte:	Analysis Breast cancer Breast Neoplasms - drug therapy Breast Neoplasms - economics Cancer therapies Conflict of Interest - economics Conflicts of interest Data analysis Data collection Decision making Disclosure Drug Industry - economics Drug Industry - trends Drug therapy Drugs FDA approval Female Humans Japan Mammography Medical care, Cost of Medical personnel Medicine and Health Sciences Patient outcomes Payments People and Places Pharmaceutical industry Pharmaceuticals Physicians Professional ethics Professionals Retrospective Studies Social Sciences Time trends (Statistics) Trends
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!